tirzepatide cardiovascular outcomes trial with versus Dulaglutide in Type 2 Diabetes Tirzepatide Matches Dulaglutide in Large

Not all insurance covers the same diagnoses (such as obesity) or weight loss medications, including semaglutide

Therefore, our awareness currently must be on monitoring new drugs which could provide a putative alternative to the current duopoly (as well as drugs that could reinforce the duopoly by resulting in either NVO or LLY or both having an oral alternative)

This translates to potential variability in quality, consistency of dosage, and the presence of impurities, compared to brand-name counterparts

Dehydration significantly contributes to fatigue and can be easily overlooked

Off-label uses extend to alopecia areata, chemotherapy-induced hair loss, and telogen effluvium following hair transplant surgery